Gilead Sciences, Inc DEFA14A, filed Mar 24, 2022

Gilead Sciences, Inc. (GILD)

DEFA14A 2022-03-24

View Original

Added on October 22, 2026

Search and read filings like this one from Claude or ChatGPT with the SEC filings MCP server →

CHECK THE APPROPRIATE BOX:
☐		Preliminary Proxy Statement
☐		Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐		Definitive Proxy Statement
☑		Definitive Additional Materials
☐		Soliciting Material under §240.14a-12

PAYMENT OF FILING FEE (CHECK ALL BOXES THAT APPLY):
☑		No fee required
☐		Fee paid previously with preliminary materials
☐		Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

		Board
Voting Items		Recommends
1.	To elect the nine director nominees named in the Proxy Statement to serve for the next year and until their successors are elected and qualified.
	Nominees:
1a.	Jacqueline K. Barton, Ph.D.		For
1b.	Jeffrey A. Bluestone, Ph.D.		For
1c.	Sandra J. Horning, M.D.		For
1d.	Kelly A. Kramer		For
1e.	Kevin E. Lofton		For
1f.	Harish Manwani		For
1g.	Daniel P. O’Day		For
1h.	Javier J. Rodriguez		For
1i.	Anthony Welters		For
2.	To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022.		For
3.	To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement.		For
4.	To approve the Gilead Sciences, Inc. 2022 Equity Incentive Plan.		For
5.	To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board adopt a policy that the Chairperson of the Board of Directors be an independent director.		Against
6.	To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board include one member from Gilead’s non-management employees.		Against
7.	To vote on a stockholder proposal, if properly presented at the meeting, requesting a 10% threshold to call a special stockholder meeting.		Against
8.	To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board publish a third-party review of Gilead’s lobbying activities.		Against
9.	To vote on a stockholder proposal, if properly presented at the meeting, requesting a Board report on oversight of risks related to anticompetitive practices.		Against


GILEAD SCIENCES, INC. ATTN: INVESTOR RELATIONS 333 LAKESIDE DRIVE FOSTER CITY, CA 94404		Your Vote Counts! GILEAD SCIENCES, INC. 2022 Annual Meeting Vote by May 3, 2022 11:59 PM ET




D72256-P67637

			For complete information and to vote, visit www.ProxyVote.com
			Control #

Smartphone users Point your camera here and vote without entering a control number		Vote Virtually at the Meeting* May 4, 2022 10:00 a.m. Pacific Time

	Virtually at: www.virtualshareholdermeeting.com/GILD2022